These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27066704)

  • 41. Evidence supporting the inclusion of strains from each of the two co-circulating lineages of H3N8 equine influenza virus in vaccines.
    Daly JM; Yates PJ; Newton JR; Park A; Henley W; Wood JL; Davis-Poynter N; Mumford JA
    Vaccine; 2004 Sep; 22(29-30):4101-9. PubMed ID: 15364463
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Updating equine influenza strains in a combined equine influenza and herpesvirus vaccine.
    Cullinane AA
    Vet J; 2004 Mar; 167(2):118-20. PubMed ID: 14975382
    [No Abstract]   [Full Text] [Related]  

  • 43. Vaccination against equine influenza: quid novi?
    Paillot R; Hannant D; Kydd JH; Daly JM
    Vaccine; 2006 May; 24(19):4047-61. PubMed ID: 16545507
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of sodium alginate adjuvant in immunization against equine influenza.
    Shechmeister IL; Aeschliman T; Kammlade WG
    Am J Vet Res; 1967 Sep; 28(126):1373-8. PubMed ID: 6069570
    [No Abstract]   [Full Text] [Related]  

  • 45. Sero-epidemiological study on equine influenza in Japan.
    Goto H; Shimizu K; Abe T; Kanamitsu M
    J Clin Microbiol; 1976 Aug; 2(2):89-93. PubMed ID: 987067
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serological evidence of infectious salmon anaemia virus (ISAV) infection in farmed fishes, using an indirect enzyme-linked immunosorbent assay (ELISA).
    Kibenge MT; Opazo B; Rojas AH; Kibenge FS
    Dis Aquat Organ; 2002 Aug; 51(1):1-11. PubMed ID: 12240966
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative measurement of equine influenza virus antibodies in horse sera by single radial hemolysis, neutralization, and hemagglutination inhibition tests.
    Yamagishi H; Nagamine T; Shimoda K; Ide S; Igarashi Y; Yoshioka I; Matumoto M
    J Clin Microbiol; 1982 Apr; 15(4):660-2. PubMed ID: 7040463
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparison of antibody responses to commercial equine influenza vaccines following annual booster vaccination of National Hunt horses - a randomised blind study.
    Gildea S; Arkins S; Walsh C; Cullinane A
    Vaccine; 2011 May; 29(22):3917-22. PubMed ID: 21419776
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Infection of dogs with equine influenza virus: evidence for transmission from horses during the Australian outbreak.
    Crispe E; Finlaison DS; Hurt AC; Kirkland PD
    Aust Vet J; 2011 Jul; 89 Suppl 1():27-8. PubMed ID: 21711279
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of recombinant modified vaccinia Ankara viral vectors for equine influenza vaccination.
    Breathnach CC; Rudersdorf R; Lunn DP
    Vet Immunol Immunopathol; 2004 Apr; 98(3-4):127-36. PubMed ID: 15010222
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Equine Infectious Anemia (EIA)].
    Kaiser A; Meier HP; Straub R; Gerber V
    Schweiz Arch Tierheilkd; 2009 Apr; 151(4):159-64. PubMed ID: 19333901
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Equine influenza vaccine performance: still learning lessons from the field.
    Newton JR
    Vet J; 2001 Mar; 161(2):107-9. PubMed ID: 11243681
    [No Abstract]   [Full Text] [Related]  

  • 53. [Efficiency of equine influenza vaccines including tetanus toxoid of combined vaccines].
    Bommeli W; Kihm U; Löhrer J; Fey H
    Schweiz Arch Tierheilkd; 1980 Jan; 122(1):27-37. PubMed ID: 7384775
    [No Abstract]   [Full Text] [Related]  

  • 54. Characterization and applications of a monoclonal antibody against infectious salmon anaemia virus.
    Falk K; Namork E; Dannevig BH
    Dis Aquat Organ; 1998 Oct; 34(2):77-85. PubMed ID: 9828403
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of the response to an accelerated immunisation schedule using a canarypox-vectored equine influenza vaccine, shortened interdose intervals and vaccination of young foals.
    Minke JM; El-Hage CM; Tazawa P; Homer D; Lemaitre L; Cozette V; Gilkerson JR; Kirkland PD
    Aust Vet J; 2011 Jul; 89 Suppl 1():137-9. PubMed ID: 21711312
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New assays to measure equine influenza virus-specific Type 1 immunity in horses.
    Paillot R; Kydd JH; MacRae S; Minke JM; Hannant D; Daly JM
    Vaccine; 2007 Oct; 25(42):7385-98. PubMed ID: 17881098
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Field studies on equine influenza vaccination regimes in thoroughbred foals and yearlings.
    Cullinane A; Weld J; Osborne M; Nelly M; Mcbride C; Walsh C
    Vet J; 2001 Mar; 161(2):174-85. PubMed ID: 11243687
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A vectored equine herpesvirus type 1 (EHV-1) vaccine elicits protective immune responses against EHV-1 and H3N8 equine influenza virus.
    Van de Walle GR; May MA; Peters ST; Metzger SM; Rosas CT; Osterrieder N
    Vaccine; 2010 Jan; 28(4):1048-55. PubMed ID: 19897066
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ISCOM-matrix-based equine influenza (EIV) vaccine stimulates cell-mediated immunity in the horse.
    Paillot R; Prowse L
    Vet Immunol Immunopathol; 2012 Jan; 145(1-2):516-21. PubMed ID: 22178272
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparison of antibody responses to commercial equine influenza vaccines following primary vaccination of Thoroughbred weanlings--a randomised blind study.
    Gildea S; Arkins S; Walsh C; Cullinane A
    Vaccine; 2011 Nov; 29(49):9214-23. PubMed ID: 21983355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.